| Pharmaceutical active ingredients: |
| Fluticasone Propionate |
| Available forms, composition and doses of Flixonase LF: |
| Spray, Metered-Dose; Nasal; Fluticasone Propionate 125 mcg / doseSpray, Metered-Dose; Nasal; Fluticasone Propionate 250 mcg / doseSpray, Metered-Dose; Nasal; Fluticasone Propionate 50 mcg / dose |
| Flixonase LF medical category: |
| Human:AdrenalsAntiasthmatic and COPD preparationsAnti-inflammatory agentsCorticosteroidsNasal decongestants and other nasal preparationsTopical corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AC17 - FluticasoneR01AD08 - FluticasoneR03BA05 - Fluticasone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |